Hai Huang
Immunology and Microbiology · The Ohio State University
Publications
304
Citations
9,756
Est. group size
~2
Recurring co-author estimate
Active years
23
Publishing since 2004
This research portfolio spans cancer immunology and liver disease, focusing on how immune cells like regulatory T cells and neutrophils interact with tumors and inflamed tissue, particularly in liver cancer, pancreatic cancer, and autoimmune hepatitis. The work also includes translational efforts such as antibody-drug conjugates and biomarker assays for guiding cancer treatment decisions. The publication record covers a broad and varied set of topics, suggesting collaboration across multiple clinical and laboratory research groups rather than a single narrow specialty.
Publication output was relatively steady at 10-19 papers per year from 2017-2022, then sharply increased to 75 in 2023 before settling back to around 21 per year in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Bridging practice and precision: a quantitative HER2 protein assay ready for clinical use in guiding trastuzumab deruxtecan therapy
Frontiers in Oncology · 2026
- Regulatory T cells in liver metastases: emerging and divergent roles in tumour progression
eGastroenterology · 2025
- Serum amyloid A1–induced intrahepatic regulatory T-cell dysfunction drives autoimmune hepatitis progression
Hepatology · 2025
- Senescent fibroblasts secrete CTHRC1 to promote cancer stemness in hepatocellular carcinoma
Cell Communication and Signaling · 2025
- Elevated albumin: a protective factor against mortality in geriatric hip fracture patients
Journal of Orthopaedic Surgery and Research · 2025
- Anti-CTGF/PD-1 bispecific antibody Y126S restrains desmoplastic and immunosuppressive microenvironment in pancreatic cancer
Journal for ImmunoTherapy of Cancer · 2025
- Expression of miR-146a in Th17 cells from rheumatoid arthritis patients and its correlation with inflammatory cytokines
Immunobiology · 2025
- Understanding the mechanism behind preoperative exercise therapy in patients with gastrointestinal cancers: a prospective randomized clinical trial
BMC Sports Science Medicine and Rehabilitation · 2025
- Discovery and functional validation of a novel lotus root-derived peptide (EWGHLGL) alleviating oxidative stress in vitro and in vivo
Food Chemistry · 2025
- CALLY index and hypertension in diabetes: A composite inflammation-nutrition-immunity marker
Science Progress · 2025
- PPY‐Induced iCAFs Cultivate an Immunosuppressive Microenvironment in Pancreatic Cancer
Advanced Science · 2025
- Oncofetal dual‑specificity phosphatase 9 drives stem‐like properties through ERK1/2‐PPARG‐SCD axis‐mediated lipid metabolism in hepatocellular carcinoma
Clinical and Translational Medicine · 2025
- An off-target effect of class A CpG-oligonucleotides on suppressing the cyclic GMP-AMP synthase signaling in fibroblastic reticular cells
Frontiers in Pharmacology · 2025
- Promising early results of MHB088C (B7-H3 ADC) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) from a phase 1/2 multicenter study.
Journal of Clinical Oncology · 2025
- Targeting Neutrophil Extracellular Traps to inhibit Colon Cancer Tumor Necrosis and Metastasis
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- The Journal of Immunology×11
- The Cambridge Structural Database×11
- Cancer Research×9
- Hepatology×8
- SSRN Electronic Journal×6
- Hongji Zhang
Immunology and Microbiology · The Ohio State University
- Ramizah Syahirah
Immunology and Microbiology · Purdue University West Lafayette
- Alexander Abreo
Immunology and Microbiology · The Ohio State University
- Andrew Stiff
Immunology and Microbiology · The Ohio State University
- Alan Y. Hsu
Immunology and Microbiology · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile